Antibody gene synthesis is a sophisticated process that involves the creation of artificial antibody genes in a laboratory setting. It encompasses the design, assembly, and production of customized DNA sequences that encode antibodies with specific properties and functions. By leveraging advanced molecular biology techniques, scientists can synthesize antibody genes that are tailored to meet the unique requirements of various research, diagnostic, therapeutic, and drug discovery applications.
de novo antibody gene synthesis (T Tanaka,, et al.,2003)
Antibody gene synthesis offers a powerful tool for researchers and scientists to study and manipulate antibodies for a wide range of purposes. It allows for the production of antibodies with desired characteristics, such as increased affinity, improved stability, or enhanced specificity. This process enables the development of novel antibodies for the treatment of diseases, the detection of specific targets in diagnostic assays, and the exploration of new therapeutic targets in drug discovery.
The main uses of antibody gene synthesis include:
Our service process is designed to provide a seamless experience from start to finish. Here's an overview of how we handle antibody gene synthesis projects:
Our service process is designed with efficiency and precision in mind, allowing you to seamlessly incorporate the synthesized antibody genes into your scientific workflow.
The genes for the anti-EGFRvIII scFvs were cloned into the pBudCE4.1 dicistronic vector. The Ig k-chain signal sequence at the 5' end of each sequence allowed the secretion of the molecule in the culture media. "Knobs-into-holes" configuration and the two cysteine residues at the 3' end of each CH3 domain stabilize the construct. Sequence corresponding to a V5 epitope was cloned at the 3' end of one anti-EGFR scFvs and the other anti-EGFR scFv has Myc as well as a 6xHis tag at 3'end.
Schematic of the RAbDMvIII antibody (P Gupta, et al.,2010)
A) 30 ug of U87vIII and U87 wild type cell lysate loaded under reducing conditions on 4-20% SDS-PAGE. A) RAbvIII recognizes 145 kDa band which corresponds to the EGFRvIII and 45 kDa unspecific protein band. A) RAbDMvIII recognizes only 145 kDa protein band. B) RAbDMvIII recognizes 170 KDa protein band in 30 ug of A431 cell lysate (cells overexpressing EGFR) and 145 kDa band in 30 ug of HC2 cell lysate under reducing conditions. B) EGFR antibody recognizes equal amount of protein in both HC2 and A431 cell lysate under reducing conditions. C) RAbDMvIII under non reducing conditions detect only 145 kDa protein band whereas RAbvIII still recognizes 145 kDa and 170 kDa protein bands in non reducing conditions. C) Actin antibody under reducing condition shows equal amount of protein loaded in the wells.
Western Blot analysis of RAbDMvIII antibody (P Gupta, et al.,2010)
We understand that you may have some questions regarding our antibody gene synthesis services. Here are answers to some frequently asked questions:
A: The turnaround time for antibody gene synthesis can vary depending on the complexity and quantity of the project. During the consultation phase, our team will provide you with an estimated timeline based on your specific requirements. We strive to provide efficient and timely delivery, ensuring that you can move forward with your projects without unnecessary delays.
A: Yes, our antibody gene synthesis services cover a wide range of species, including humans, mice, rats, and more. We understand that different research projects may require antibodies specific to different species. Please let us know your specific requirements, and we will accommodate accordingly to ensure that the synthesized antibody genes align with the desired species.
A: Antibody gene synthesis has numerous applications across various fields. It plays a crucial role in research, enabling scientists to study specific targets, investigate diseases, and develop new therapies. Furthermore, antibody gene synthesis is utilized in diagnostics to detect specific markers or antigens, as well as in drug discovery to identify potential therapeutic targets. The ability to produce custom antibodies through gene synthesis opens up a world of possibilities for advancing scientific knowledge and improving human health.
A: Requesting a quote for our antibody gene synthesis services is easy. Simply contact our team via email or phone, and we will be happy to assist you. We understand that each project is unique, and we will work closely with you to provide a customized solution based on your specific needs. Our team is dedicated to delivering high-quality antibody gene synthesis services that align with your goals and expectations.
We look forward to the opportunity to collaborate with you on your antibody gene synthesis projects. Contact us today to discuss your requirements and explore how our services can support your research, diagnostic, therapeutic, or drug discovery endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.